Verastem Oncology Reports Fourth Quarter and Full-Year 2019 Financial Results

Go back to Verastem Oncology Reports Fourth Quarter and Full-Year 2019 Financial Results
VERASTEM SHS (NASDAQ: VSTM) Delayed: 7.77 +0.03 (0.39%)
Previous Close $7.74    52 Week High $2.43 
Open $7.59    52 Week Low $1.05 
Day High $7.78    P/E N/A 
Day Low $7.39    EPS $-1.79 
Volume 1,260,602